This exploration examines creativity in drug policy-making, suggesting innovative connections for improved outcomes.
I have been thinking about creativity in the policy‐making space, especially drug policy. I have been blessed to work with a few folks who are able to connect things that do not seem connected. They do so with the goal of producing good policy, making things better for others.
No takes yet. Share an insight, caveat, or question.
Rob Kent (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: